Malats N - Search Results

1

Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis.

Pineda S, Milne RL, Calle ML, Rothman N, López de Maturana E, Herranz J, Kogevinas M, Chanock SJ, Tardón A, Márquez M, Guey LT, García-Closas M, Lloreta J, Baum E, González-Neira A, Carrato A, Navarro A, Silverman DT, Real FX, Malats N. Pineda S, et al. Among authors: malats n. PLoS One. 2014 May 12;9(5):e89952. doi: 10.1371/journal.pone.0089952. eCollection 2014. PLoS One. 2014. PMID: 24818791 Free PMC article.

2

Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators.

Malats N, Porta M, Piñol JL, Corominas JM, Rifà J, Real FX. Malats N, et al. J Clin Oncol. 1995 Jul;13(7):1679-86. doi: 10.1200/JCO.1995.13.7.1679. J Clin Oncol. 1995. PMID: 7602358

3

Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. PANKRAS I Project Investigations.

Porta M, Malats N, Piñol JL, Rifà J, Andreu M, Real FX. Porta M, et al. Among authors: malats n. J Clin Epidemiol. 1994 Sep;47(9):1069-79. doi: 10.1016/0895-4356(94)90123-6. J Clin Epidemiol. 1994. PMID: 7730910

4

Re: Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.

Malats N, Porta M, Fernandez E, Real FX. Malats N, et al. J Natl Cancer Inst. 1994 Sep 7;86(17):1353-4; author reply 1355. doi: 10.1093/jnci/86.17.1353-a. J Natl Cancer Inst. 1994. PMID: 7914938 No abstract available.

5

DDT and pancreatic cancer.

Malats N, Real FX, Porta M. Malats N, et al. J Natl Cancer Inst. 1993 Feb 17;85(4):328-9. doi: 10.1093/jnci/85.4.328. J Natl Cancer Inst. 1993. PMID: 8426376 No abstract available.

6

Serum anti-p53 antibodies and prognosis of patients with small-cell lung cancer.

Rosenfeld MR, Malats N, Schramm L, Graus F, Cardenal F, Viñolas N, Rosell R, Torà M, Real FX, Posner JB, Dalmau J. Rosenfeld MR, et al. Among authors: malats n. J Natl Cancer Inst. 1997 Mar 5;89(5):381-5. doi: 10.1093/jnci/89.5.381. J Natl Cancer Inst. 1997. PMID: 9060960

7

Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators.

Malats N, Porta M, Corominas JM, Piñol JL, Rifà J, Real FX. Malats N, et al. Int J Cancer. 1997 Mar 17;70(6):661-7. doi: 10.1002/(sici)1097-0215(19970317)70:6<661::aid-ijc6>3.0.co;2-t. Int J Cancer. 1997. PMID: 9096646

8

Learning from case reports: diagnostic issues in an epidemiologic study of pancreatic cancer.

Soler M, Porta M, Malats N, Guarner L, Costafreda S, Gubern JM, García-Olivares E, Andreu M, Real FX. Soler M, et al. Among authors: malats n. J Clin Epidemiol. 1998 Dec;51(12):1215-21. doi: 10.1016/s0895-4356(98)00130-9. J Clin Epidemiol. 1998. PMID: 10086813

9

Human cancer, carcinogenic exposures and mutation spectra.

Vineis P, Malats N, Porta M, Real FX. Vineis P, et al. Among authors: malats n. Mutat Res. 1999 Mar;436(2):185-94. Mutat Res. 1999. PMID: 10095140 Review. No abstract available.

10

Correction: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis.

Malats N, Real FX. Malats N, et al. N Engl J Med. 1999 May 20;340(20):1592-3. doi: 10.1056/NEJM199905203402014. N Engl J Med. 1999. PMID: 10336360 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

329 results

Search Page

Filters